<DOC>
	<DOCNO>NCT01749202</DOCNO>
	<brief_summary>The purpose study assess effect stearidonic acid use food ingredient eicosapentaenoic enrichment red blood cell membrane Omega-3 Index men woman .</brief_summary>
	<brief_title>Effects Stearidonic Acid-Containing Foods Eicosapentaenoic Acid Levels Red Blood Cells Omega-3 Index</brief_title>
	<detailed_description />
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Arrest</mesh_term>
	<mesh_term>Death</mesh_term>
	<mesh_term>Death , Sudden , Cardiac</mesh_term>
	<criteria>1 . Male female , 21 65 year age . 2 . BMI ) ≥18.00 &lt; 40.00 kg/m2 . 3 . No health condition would prevent him/her fulfil study requirement judge Investigator basis medical history routine laboratory test result . 4 . Willing avoid alcohol consumption 24 h prior every clinic visit . 5 . No plan change smoke habit study period . 6 . Willing maintain stable body weight , activity level dietary pattern except use study product , direct . 7 . Understands study procedure sign form provide informed consent participate study authorization release relevant protect health information study Investigator . 1 . Subject coronary heart disease coronary heart disease risk equivalent include follow : Diabetes mellitus Clinical sign atherosclerosis include peripheral arterial disease , abdominal aortic aneurysm , carotid artery disease Presence multiple risk factor give person great 20 % chance develop coronary artery disease within 10 year . 2 . Abnormal laboratory test result clinical significance 3 . TG ≥400 mg/dL visit 1 , week 2 . 4 . Smokes one pack cigarettes ( 20 cigarette ) per day . 5 . History presence clinically important renal , hepatic , pulmonary , biliary , gastrointestinal , neurologic endocrine disorder judgment Investigator , would interfere subject 's ability provide inform consent , comply study protocol Stable , treat hypothyroidism allow . 6 . Uncontrolled hypertension 7 . Unstable use within four week visit 1 ( week 2 ) antihypertensive medication thyroid hormone replacement . 8 . Use lipidaltering drug , include statin , bile acid sequestrants , cholesterol absorption inhibitor , fibrates , prescription formulation niacin within four week visit 1 ( week 2 ) throughout study . If subject need wash drug , he/she consent ask return four week washout . 9 . Use EPA/DHA drug supplement within four month visit 1 10 . Frequent use ( twice per month ) nonstudyrelated EPA/DHA contain enrich food ( DHAenriched eggs ) within four month visit 1 , week 2 avoidance enrich food throughout study period 11 . Use seed oil contain significant amount ALA 12 . Consumption fatty fish ( salmon , herring , mackerel , albacore tuna , sardine ) twice per month 13 . Use dietary supplement know alter lipid metabolism 14 . Use weightloss medication 15 . Use weight loss supplement program within four week visit 1 16 . Known allergy sensitivity study product ingredient study product . 17 . Subject unwilling consume study product ( bar , beverage capsule ) base result taste test study product visit 1 , week 2 . 18 . Subject history presence cancer prior two year , except nonmelanoma skin cancer 19 . Females pregnant , plan pregnant study period , lactate , woman childbearing potential unwilling commit use medically approve form contraception throughout study period . The method contraception must record source documentation . 20 . Current recent history ( within 12 month visit 1 , week 2 ) strong potential alcohol substance abuse . Alcohol abuse define &gt; 14 drink per week ( 1 drink = 12 oz beer , 5 oz wine , 1 ½ oz distil spirit ) . 21 . Exposure nonregistered drug product within 30 day prior screen visit ( visit 1 , week 2 ) .</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Omega 3 fatty acid</keyword>
	<keyword>Omega 3 Index</keyword>
	<keyword>Stearidonic acid ( SDA )</keyword>
	<keyword>Red Blood Cells</keyword>
	<keyword>Lipids</keyword>
</DOC>